Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
M. Serino, C. Freitas, M. Martins, P. Ferreira, C. Cardoso, F. Veiga, V. Santos, D. Araújo, H. Novais-Bastos, A. Magalhães, H. Queiroga, G. Fernandes, V. Hespanhol
10.1016/j.pulmoe.2022.03.003